TABLE 4.

Relative risk of severe outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients exposed to glucocorticoids, by cumulative prednisolone-equivalent dose <2000 mg (moderate) or ≥2000 mg (high)

Outcome	Dose	Events		Relative risk (95% CI)
		Exposed	Unexposed	Crude	Adjusted
Hospital admission	Moderate	38 (n=69)	3373 (n=36 200)	5.91 (4.76–7.33)	1.20 (0.89–1.62)
	High	45 (n=67)	3373 (n=36 200)	7.21 (6.08–8.55)	1.47 (1.15–1.89)
ICU admission	Moderate	5 (n=69)	400 (n=36 200)	6.56 (2.80–15.34)	1.92 (0.83–4.46)
	High	5 (n=67)	400 (n=36 200)	6.75 (2.89–15.78)	1.60 (0.62–4.14)
Death	Moderate	18 (n=69)	658 (n=36 200)	14.35 (9.58–21.50)	1.83 (1.08–3.11)
	High	24 (n=67)	658 (n=36 200)	19.71 (14.18–27.39)	2.96 (2.00–4.37)

ICU: intensive care unit.